Spectrum of β-Thalassemia Mutations in the Eastern Province of Saudi Arabia

REFERENCES

• Steinberg MH, Forget BG, Higgs DR, Weatherall DJ. Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management. Cambridge: Cambridge University Press, 2001.
   Google Scholar
• Weatherall DJ. The thalassaemias. In: Stamatoyannopoulos G, Majerus PH, Varmus H, Nienhuis AW, eds. The Molecular Basis of Blood Diseases. Philadelphia, PA: W. B. Saunders Company; 1994:157–205.
   Google Scholar
• Thein SL. Genetic modifiers of β-thalassemia. Haematologica. 2005;90(5):649–660.
   PubMed Web of Science ®Google Scholar
• Galanello R, Origa R. β-Thalassemia. J Rare Dis. 2010;5:11–25.
   Google Scholar
• Uda M, Galanello R, Sanna S, Lettre G, Sankaran VG, Chen W, Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of phenotype of β-thalassemia. Proc Natl Acad Sci USA. 2008;105:1620–1625.
   PubMed Web of Science ®Google Scholar
• Hardison RC, Chui DHK, Giardine B, Riemer C, Patrinos GP, Anagnou N, et al. HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat. 2002;19(3):225–331 (http//globin.cse.psu.edu).
   Google Scholar
• Flint J, Harding RM, Boyce AJ, Clegg JB. The population genetics of the haemoglobinopathies. Baillière's Clin Haematol. 1998;11(1):1–51.
   PubMed Web of Science ®Google Scholar
• Cao A, Gossens M, Pirastu M. β-Thalassaemia mutations in Mediterranean populations. Br J Haematol. 1989; 71(3):309–312.
   PubMed Web of Science ®Google Scholar
• Zahed L. The spectrum of β-thalassaemia mutations in the Arab populations. J Biomed Biotechnol. 2001;1(3):129–132.
   PubMedGoogle Scholar
• El-Hazmi MA, Al-Swailem AR, Warsy AS. Molecular defects in β-thalassaemias in the population of Saudi Arabia. Hum Hered. 1995;45(5):278–285.
   PubMed Web of Science ®Google Scholar
• Hasounah FH, Sejeny SA, Omer JA, Old JM, Oliver RW. Spectrum of β-thalassaemia mutations in the population of Saudi Arabia. Hum Hered. 1995;45(4):231–234.
   PubMedGoogle Scholar
• El-Harth EH, Kuhnau W, Schmidtke J, Stuhrmann M, Nasserallah Z, Al-Shahiri A. Identification and clinical presentation of β thalassaemia mutations in the Eastern region of Saudi Arabia. J Med Genet. 1999;36(12):935–937.
   PubMed Web of Science ®Google Scholar
• Al-Ali AK, Al-Ateeq S, Mamwerdi BW, Al-Sowayan S, Al-Madan M, Al-Muhanna F, Molecular bases of β-thalassemia in the Eastern Province of Saudi Arabia. J Biomed Biotechnol. 2005:4:1–4.
   Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215–1216.
   PubMed Web of Science ®Google Scholar
• Pembrey ME, Perrine RP, Wood WG, Weatherall DJ. Sickle β0 thalassemia in the Eastern Saudi Arabia. Am J Hum Genet. 1980;32(1):26–41.
   PubMedGoogle Scholar
• Perrine RP, Pembrey ME, John P, Perrine S, Shoup F. Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjects. Ann Intern Med. 1978;88(1):1–6.
   PubMed Web of Science ®Google Scholar
• Henderson S, Timbs A, McCarthy J, Gallienne A, Van Mourik M, Masters G, Incidence of haemoglobinopathies in various populations – the impact of immigration. Clin Biochem. 2009;42(18):1745–1756.
   PubMed Web of Science ®Google Scholar
• Jassim N, Merghoub T, Pascaud O, al Mukharraq H, Ducrocq R, Labie D, Molecular basis of β-thalassemia in Bahrain: an epicenter for a Middle East specific mutation. Ann NY Acad Sci. 1988;850:407–409.
   Google Scholar
• Adekile AD, Gu L-H, Baysal E, Haider MZ, al-Fuzae L, Aboobacker KC, Molecular characterization of α-thalassemia determinants, β-thalassemia alleles, and βS haplotypes among Kuwaiti Arabs. Acta Haematol. 1994;92(4):176–181.
   PubMed Web of Science ®Google Scholar
• Quaife R, al-Gazali L, Abbes S, Fitzgerald P, Fitches A, Valler D, The spectrum of β-thalassemia mutations in the UAE national population. J Med Genet. 1994;31(1):59–61.
   PubMed Web of Science ®Google Scholar
• Daar S, Hussein HM, Merghoub T, Krishnamoorthy R. Spectrum of β-thalassemia mutations in Oman. Ann NY Acad Sci. 1998;850:404–406.
   PubMed Web of Science ®Google Scholar
• Patrinos GP, Giardine B, Riemer C, Miller W, Chui DH, Anagnou NP, et al. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32 (Database issue):D537–D541 (http//globin.cse.psu.edu).
   Google Scholar
• Moreno I, Bolufer GP, Perez SM. The molecular changes in thalassemias in Spain. A review of existing studies. Medicina Clinica. 1999;113(20):789–794.
   PubMedGoogle Scholar
• Voon HPJ, Vadolas J. Controlling α-globin: a review of α-globin expression and its impact on β-thalassemia. Haematologica. 2008;93(12):1868–1876.
   PubMed Web of Science ®Google Scholar
• Wonke B. Bone disease in β-thalassaemia major. Br J Haematol. 1998;103(4):897–901.
   PubMed Web of Science ®Google Scholar
• Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood. 2002;99(1):36–43.
   PubMed Web of Science ®Google Scholar
• Walter PB, Macklin EA, Porter J, Evans P, Kwiatkowski JL, Neufeld EJ, Inflammation and oxidant-stress in β-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica. 2008;93(6):817–825.
   PubMed Web of Science ®Google Scholar
• Neufeld EJ. Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood. 2006;107(9):3436–3441.
   PubMed Web of Science ®Google Scholar